# FDA Inspection 1169079 - Daniel M. Duncanson, M.D. - April 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/daniel-m-duncanson-md/510cb9f6-44d2-4f87-b872-3b9b978eccfb
Source feed: FDA_Inspections

> FDA Inspection 1169079 for Daniel M. Duncanson, M.D. on April 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169079
- Company Name: Daniel M. Duncanson, M.D.
- Inspection Date: 2022-04-28
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169079 - 2022-04-28](https://www.keypedia.com/records/fda_inspections/daniel-m-duncanson-md/7a698f8a-979b-40d0-b9f3-fdb5834895c6)

Company: https://www.keypedia.com/companies/daniel-m-duncanson-md/13a4900f-5a96-443d-ab6b-b979fcb9c427

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d